Latest News and Press Releases

Omada Health to Announce Third Quarter 2025 Financial Results and Host Conference Call on November 6, 2025.

Omada Health reports second quarter 2025 results. Revenue of $61 million, up 49%. 52% member growth and significant progress toward profitability.

JACKSONVILLE, Fla., July 23, 2025 (GLOBE NEWSWIRE) -- CSX Corp. (NASDAQ: CSX) today announced second quarter 2025 operating income of $1.28 billion compared to $1.45 billion in the prior year...

JACKSONVILLE, Fla., Jan. 23, 2025 (GLOBE NEWSWIRE) -- CSX Corp. (NASDAQ: CSX) today announced fourth quarter 2024 operating income of $1.11 billion compared to $1.32 billion in the prior year...

JACKSONVILLE, Fla., Dec. 18, 2024 (GLOBE NEWSWIRE) -- CSX Corp. (NASDAQ: CSX) will release fourth quarter financial and operating results after the market close on Thursday, January 23, 2025. This...

JACKSONVILLE, Fla., Jan. 04, 2024 (GLOBE NEWSWIRE) -- CSX Corp. (NASDAQ: CSX) will release fourth quarter financial and operating results after the market close on Wednesday, January 24, 2024. This...

JACKSONVILLE, Fla., Sept. 21, 2023 (GLOBE NEWSWIRE) -- CSX Corp. (NASDAQ: CSX) will release third quarter financial and operating results after the market close on Thursday, October 19, 2023. This...

MONTREAL, May 16, 2022 (GLOBE NEWSWIRE) -- Dynacor Gold Mines Inc. (TSX: DNG) (Dynacor or the Corporation) released its unaudited condensed interim consolidated financial statements and the...

Paltusotine Phase 3 PATHFNDR program in acromegaly initiated in 2Q 2021 Phase 1 data for CRN04894 and CRN04777 expected in mid-2021 SAN DIEGO, May 06, 2021 (GLOBE NEWSWIRE) -- Crinetics...

Advancing paltusotine into a Phase 3 program for acromegaly following an FDA meeting Phase 1 clinical proof-of-concept data for CRN04894 and CRN04777 expected in 1H 2021 and mid-2021, respectively ...